Blackstone Technology Group
2
44M
2
0.08
1
- Areas of investment
Summary
Blackstone Technology Group is the famous Corporate Investor, which was founded in 1997. The company was established in North America in United States. The main department of described Corporate Investor is located in the Worcester.
The fund was created by Rakesh Agrawal.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Blackstone Technology Group, startups are often financed by Satter Investment Management, Novartis Venture Fund, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are Woodside Fund, WI Harper Group, Surveyor Capital.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Web Hosting, Internet. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Annexon Biosciences, StreetFusion
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.08
- Investments by industry
- Finance (1)
- Internet (1)
- Web Hosting (1)
- Financial Services (1)
- Health Diagnostics (1) Show 4 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Annexon Biosciences | 19 Dec 2018 | Biotechnology, Health Care, Health Diagnostics, Life Science, Therapeutics | Late Stage Venture | 75M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.